CV Sciences, Inc. (CVSI) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	8-K	10-Q	10-Q	10-Q	10-K	8-K	10-Q
Assets
Current assets:
Cash	1.7	0.7						2.5
Accounts receivable, net	0.6	0.7	0.7	1.0	0.9	2.0	1.8	1.1
Inventory	5.8	6.5	7.2	7.4	8.2	8.6	8.9	9.2
Prepaid expenses and other	0.4	2.1	3.1	3.2	3.4		1.9	1.8
Total current assets	8.5	10.0	12.2	12.6	15.1	14.2	14.2	15.0
Property and equipment, net	0.5	0.5	0.6	0.7	1.1	1.7	2.1	2.5
Right of use assets	0.2		0.3	0.3
Intangibles, net	0.3	0.3	1.5	1.5	1.5	1.5	3.7	3.7
Other assets	0.4	0.5	0.6	0.6	0.6	0.7	0.7	1.0
Total assets	9.9	11.5	15.2	15.8	18.3	18.1	23.6	27.8

Liabilities and stockholders' equity (deficit)
Current liabilities:
Accounts payable	2.2	2.4	2.2	2.5	2.7	2.6	1.5	0.6
Accrued expenses	3.5	3.2	9.7	9.9	10.3	10.9	10.8	10.2
Operating lease liability - current	0.1		0.1	0.1
Debt, net of discounts	0.0
Total current liabilities	5.8	6.3	13.5	13.6	14.2	14.5	12.3	14.6
Operating lease liability - net of current portion	0.1
Deferred tax liability	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2
Total liabilities	6.0	6.4	13.8	13.9	14.3	14.5	12.5	17.8

Commitments and contingencies (Note 9)
Stockholders' equity (deficit)
Preferred stock, par value $0.0001; 10,000 shares authorized; 1 share issued as of June 30, 2023 and December 31, 2022; and no shares outstanding as of June 30, 2023 and December 31, 2022					0.3
Common stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	87.2	87.0	86.7	86.2	85.4	83.0	81.7	80.5
Accumulated deficit	-83.3	-82.0	-85.4	-84.3	-81.7	-79.5	-70.6	-70.6
Total stockholders' equity (deficit)	3.9	5.0	1.4	1.9	4.0	3.5	11.1	10.0
Total liabilities and stockholders' equity (deficit)	9.9	11.5	15.2	15.8	18.3	18.1	23.6	27.8